Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Shanghai At Risk for Alzheimer's Disease: a Cohort Study

NCT05597410 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT05597410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05597410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Shanghai At Risk for Alzheimer's Disease: a Cohort Study
Lead sponsor
Ruijin Hospital
Phase
Observational
Overall status
Recruiting
Start date
March 1, 2022
Completion date
March 31, 2030
Enrollment
3,418 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, cognitive impairment, dementia, neurocognitive disorders, neurodegenerative diseases